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ABSTRACT 
Organosilanes are advantageous in organic synthesis due to their ability to act as 
both stable products and reactive intermediates. A stereospecific one-pot cascade reaction 
that converts chiral allylic silanes into chiral heterocycles was developed using Lewis acid 
catalysis. We report on the development of this cascade reaction, optimization to benchtop-
scale chemistry, and preliminary investigation into the synthetic scope. In our studies, we 
were successful in varying the cyclization ring size, investigating cyclization preference in 
the presence of multiple electrophilic leaving groups, and altering the functional groups 
present on the aldehyde starting material. Ultimately, we envision this method will be 
useful in the synthesis of a variety of enantioenriched heterocycles found in bioactive 
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Background on Allylic Silanes 
 
1.1 ORGANOSILANES AS TOOLS IN ORGANIC SYNTHESIS 
Organosilanes are valuable compounds due to their applications in medicinal 
chemistry and as reagents for chemical synthesis. In pharmaceutical pursuits, the 
replacement of carbon with silicon has a twofold effect. In some cases, exchanging a 
carbon atom for a silicon atom has been shown to improve therapeutic effects of known 
drugs 1-3 (Figure 1).1 While the two atoms have similar electronic properties, there are 
subtle differences between the two such as the increased C–Si versus C–C bond length. 
This can result in drastic in vitro effects, such as modified selectivity or metabolic rate.2 
Furthermore, sila-substitution can lead to better definitions of intellectual property in the 
pharmaceutical industry, making these molecules more enticing for companies to invest 






Figure 1. Sila-substituted analogues of known drugs. 
 
In order to synthesize complex organic compounds such as the bioactive molecules 
(1-3) in Figure 1, the synthetic organic chemist must construct these molecules in a 
stepwise fashion, drawing on reactions available to them from their synthetic toolkit. The 
use of organosilicon compounds as reagents has garnered increasing interest in the organic 
chemistry communitiy.3–6 The advantages these reagents are numerous – stability under a 
variety of reaction parameters, reactivity under mild conditions, and functional group 
compatibility for use on a wide variety of compounds. These benefits open up new avenues 
for reaction design, thus adding new reaction methods to the synthetic organic chemist’s 
toolkit. In comparison to other organometallic reagents, silicon is significantly less ionic 
than other metal atoms, only forming a weakly polar bond with carbon. However, this 
property makes silicon-based groups generally unreactive toward electrophilic species. 
Nevertheless, given certain conditions, reactions with electrophiles can occur.  
 
1.2 REACTIVITY OF ALLYLIC SILANES WITH ELECTROPHILES 
In terms of reaction development, the allyl silyl motif has become an increasingly 

































reactions with electrophilic compounds. Silyl groups are electron-donating and therefore  
are capable of stabilizing carbocations that are β to the silicon atom. More specifically, in 
the case of allylic silanes, the carbon-silicon σ bond exhibits conjugation with the π bond of 
the olefin.7 This electronic structure increases the energy of the highest occupied molecular 
orbital and therefore allylic silane motifs (4) can be highly reactive with electrophiles, 
forming carbocation intermediate 5 en route to 6 (Figure 2). Additionally, allylic silanes do 
not readily isomerize like their allyl metal counterparts; this isomerization only occurs at 
temperatures of 500 °C, thus making reactions of allylic silanes with electrophiles 
regiospecific, unlike with other allyl metal compounds.8  
 
 
Figure 2. General reaction scheme of allylic silanes with electrophiles. 
 
1.3 LEVERAGING REACTIVITY TO MAKE STEREOSPECIFIC 
TRANSFORMATIONS 
One of the first reactions between allylic silanes and carbonyl compounds was 
performed in 1974 in order to do synthesize homoallylic alcohols. Calas and coworkers 
reported the synthesis of homoallylic alcohols using activated organosilanes, such as allylic 
silanes, in the presence of catalytic, chlorinated Lewis acids (e.g. aluminum trichloride, 
gallium trichloride, and indium trichloride).9,10 Although the work was groundbreaking for 
its unique use of organosilanes as reagents, the scope remained limited to only two 
chlorinated carbonyl substrates (8): chloral and chloracetone (Figure 3). Another 






shortcoming of the reaction was the additional desilylation step required to get to the 
alcohol product, as the addition of the allylic silane (7) to the chlorinated carbonyl 
compounds (8) results in a silyl ether intermediate (9). In terms of reaction development, 
this linear sequence left room for further studies to optimize a one-step procedure. 
Furthermore, a more expansive substrate scope beyond the two chlorinated carbonyl 
substrates became necessary for this reaction to have broad-reaching synthetic utility.  
 
 
Figure 3. Selected reactions of allylic silanes reacting with chlorinated aldehydes and 
ketones, catalyzed by chlorinated catalytic Lewis acid. 
 
At roughly the same time as Calas’ work, a major breakthrough happened in the 
field. Sakurai et al. reported the reaction between allylic silanes and Lewis acid-activated 
carbonyl compounds, expanding the scope to a wide variety of carbon electrophiles (11) 
with varying degrees of success. Addition of the allyl fragment and loss of the silyl group 
provides γ,δ-unsaturated alcohols (Figure 4). This stereospecific reaction built upon 
previous work done by Calas and coworkers through use of stoichiometric titanium 
tetracholoride as the activating Lewis acid. Through use of this reagent, the scope of carbon 
electrophiles that could react with allylic silanes expanded to include aliphatic, aromatic, 
and alicyclic carbonyl compounds (11).7  
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10a: R1 = H, R2 = CCl3
55% yield








Figure 4. General reaction scheme for the Hosomi-Sakurai allylation between 
trimethylallylsilane and selected subtrates. 
 
When analyzing the results in Figure 4, certain patterns begin to emerge regarding 
steric demand and yield. Linear carbonyl compounds (11a,11c-f) tend to react quickly with 
high yields. The addition of steric bulk at the β or γ carbons both decreases yield and 
requires an increase in reaction time, as with isobutyraldehyde (11b) and 4-methylpentan-
2-one (11g). As the sterically encumbering groups increase in distance from the site of the 
reaction, the yield increases and less reaction time is needed, as with 3-phenylpropanal 
(11c). These trends also explain the decrease in yield of cyclic ketones (11h,i) with the 
decrease in ring size. Smaller rings are more rigid and are more susceptible to steric issues.  
The Sakurai allylation is relatively simple to carry out in a synthetic chemistry 
laboratory. Typically the reaction is run under a nitrogen atmosphere with dichloromethane 
as the solvent, and an aqueous workup is performed in order to protonate the alkoxide to 






















































relatively short timescales, such as 0.5 to 10 minutes (Figure 4). When exposed to the 
Lewis acid for extended periods of time, the yield of the desired product diminishes due to 
side reactions such as polymerization.  
While the Sakurai allylation provides a robust method to produce alcohols from the 
acid-catalyzed reaction between allylic silanes and carbonyl compounds, the value of the 
alcohol product is often overlooked. The alcohol functional group can be viewed as a 
stopping point in a synthetic scheme rather than a useful tool for chemists in their pursuit of 
constructing complex molecules. Building upon this notion, the reaction conditions 
reported by Sakurai became the starting point for our own work. Instead of isolating the 
homoallylic alcohol (14), we envisioned avoiding the aqueous workup and hypothesized 
whether or not the alcohol intermediate could be used to synthesize a heterocyclic product 
(15) in situ (Figure 5). Progressing this established methodology onward to more complex 
and synthetically challenging heterocycle motifs is the core focus of this thesis work.  
 
 
Figure 5. Conceptual basis for thesis work stemming from the Sakurai allylation. 
 
1.4 ALTERNATE AND OPTIMAL REACTION CONDITIONS 
In these allylation reactions, a Lewis acid is required to activate the carbonyl 
moiety. Sakurai first reported the use of titanium tetrachloride which provides relatively 
















compounds. However, this Lewis acid is not always optimal. In fact, Sakurai reports on 
using other Lewis acids on a case-by-case basis, such as boron trifluoride diethyl etherate, 
ethylalumnium dichloride, and tin tetrachloride.7,11 Even still, titanium tetrachloride tends 
to be the more universally accepted activating agent for these allylation reactions. 
A shortcoming of the Sakurai allylation reaction is that it requires stoichiometric 
amounts of Lewis acid in order to activate the carbonyl species present in the reaction 
mixture. However, stoichiometric quantities of Lewis acid are not ideal when it comes to 
method development. It is economically inefficient and, depending on the reagent, can be 
somewhat dangerous. Therefore, it is desirable to develop methods which use catalytic 
amounts of the Lewis acid.  
Catalytic Lewis acids were discovered to work in the Sakurai allylation with 
aldehydes nearly two decades later using a chiral (axyloxy)borane catalyst. Ishihara and 
coworkers report their synthesis of the chiral (axyloxy)borane catalyst (8) and showcase its 
utility in terms of great yields, good diastereoselectivity, and excellent enantiomeric excess, 
especially when using substituted allylic silane reagents (17).12 They found that 20 mol% 
loading of the catalyst to be the most successful, as lower catalyst loading resulted in severe 
decreases in yield. The catalyst produces silylated homoallylic alcohols (19) and upon 
further treatment with tetrabutylammonium fluoride, the desilyated alcohol product was 
observed. Yields were improved by substituting the allylic portion of the silyl starting 
material, due to improved asymmetric induction (Figure 6). Although they developed a 
catalytic allylation reaction, the types of carbonyl compounds that could participate in this 






Figure 6. Asymmetric allylation with a chiral (acyloxy)borane catalyst. 
 
Due to the need for a catalytic Sakurai allylation that could react with more 
complex aldehydes and ketones, efforts continued in order to develop methods with more 
expansive substrate scopes, particularly those that included cyclic ketones (20). In 2005, 
Wadamoto and Yamamoto reported a method which used a silver catalyst to form chiral 
homoallylic alcohols from allyltrialkoxysilanes (21) and ketones.13 Using (R)-
DIFLUOROPHOS (22) as a ligand that complexes with silver fluoride (1:1 molar ratio), 
Wadamoto was able to access a wide variety of homoallylic alcohol products (10) with 



























R1 R2 Yield (%) ee (%)
OH
Me Me 88 77
Me Me 81 73
Me 71 48
Me
Me Me 70 63
Me 65 63
Me Me 55 54

















Figure 7. Catalytic, asymmetric Sakurai allylation with various ketone substrates. 
 
It is evident from these selected reactions that the Sakurai allylation has been 
elaborated upon extensively since its initial report. Each of these reactions has showcased a 
way in which one could access enantioenriched homoallylic alcohol products in good 
yields, demonstrating the synthetic value of this transformation. 
 
1.5 THE SAKURAI ALLYLATION IN TOTAL SYNTHESES 
Reactions between aldehydes and allylic silanes, particularly the Sakurai allylation 
reaction, have been used in several total syntheses in the past few decades. One synthesis 
that showcases the Sakurai allylation is Williams’ asymmetric construction of (+)-






20l: n = 1
89% yield, 91% ee;
20m: n = 2
63% yield, 93% ee;
20n: n=3











































































for its cytotoxic and potential antitumor activity. Using boron trifluoride diethyl etherate as 
the Lewis acid for the Sakurai allylation, Williams was able to construct the hydroxyl 
stereocenter with moderate selectivity and good yield (60%).14 The alcohol (24) is used to 
later form the heterocyclic ring of the macrolide (Figure 8). Although the diastereomeric 
ratio of 2:1 leaves room for improvement, the minor diastereomer can be converted to the 
desired isomer through use of the Mitsunobu reaction which inverts the stereochemistry at 
the site of the carbon-oxygen bond. The allylation product is then advanced to complete the 
first total synthesis of (+)-amphidinolide P. 
 
 
Figure 8. Williams’ use of the Sakurai allylation has poor diastereocontrol, but the 
undesired isomer can be inverted with a Mitsunobu reaction. 
 
In 2003, the Trost laboratory used the Sakurai allylation in synthesis of three 
furaquinocins (28a and 28b), a class of molecules known primarily for their antibiotic 
activity but which also show cytotoxic and antihypertensive activity.15 The aldehyde 
moiety on the bicyclic core of the molecule (26) was used as a functional handle for the 
allylation step in the total synthesis (Figure 9). The diastereoselective Sakurai allylation of 
the core with allyltrimethylsilane (7) was able to introduce the alcohol stereocenter with 



























olefin could be elaborated upon using alkene metathesis to complete the total synthesis of 
furaquinocin A and furaquinocin B.  
 
 
Figure 9. Late stage Sakurai allylation in Trost’s synthesis of furaquinocins. 
 
1.6 OTHER REACTIONS BETWEEN ALLYLIC SILANES AND 
ALDEHYDES 
While all of the previous examples include the loss of the silyl group upon addition 
of the allyl fragment to the aldehyde, other transformations between allylic silanes and 
aldehydes have been reported. De Fays and coworkers were able to synthesize 
enantioenriched β-hydroxy allylsilanes (32) using allylic silanes (28).16 Through 
transmetallation with stoichiometric n-butyllithium and then a chiral allyltitanium 
compound (29), stereochemical information is transferred from the organometallic reagent 
to the final cyclic diene (32), creating two stereocenters on the molecule with good yield 
and in excellent enantioselectivity (Figure 10).  
It has been established that the Sakuai allyation can be initiated through activation 



























R1 = CH2OH, R2 = Me
28b: furaquinocin B 







trifluoride etherate. Similarly, chiral organoborane compounds can be used in place of a 
chiral titanium complex in order to prepare chiral hydroxysilanes with excellent yields.  
 
 
Figure 10. Asymmetric allylmetallation of aliphatic aldehydes with an allylic silane. 
 
According to Chabaud et al., the use of organoboranes is of growing interest to the 
organic community, as it provides a means to both efficiently and reliably synthesize chiral 
allylic silanes.5 A γ-silylallylboronate intermediate (34) can be synthesized easily with one 
step from a simple allylic silane starting material (Figure 11). This intermediate is then 
exposed to an aldehyde with a terminal olefin, and upon a basic workup, β-
hydroxyallylsilane 36 is formed in great yield (86%) and with excellent enantiomeric 
excess (94%).17 Roush and coworkers do not report on an extensive substrate scope using 
this method, but were able to run it on an additional aldehyde containing benzyl ether 
functional groups in some of their later studies.18 They can elaborate these β-
hydroxyallylsilane intermediates using Grubbs’ second-generation catalyst with ring 




















































Figure 11. Synthesis of chiral β-hydroxyallylsilanes can undergo ring-closing 
metathesis to a cyclic form, starting from a γ-silylallylboronate intermediate. 
 
1.7 SELECTED METHODS TO SYNTHESIZE CHIRAL ALLYLIC 
SILANES 
1.7.1 STEREOSPECIFIC APPROACHES 
Although recent work by Roush showcases a unique method with which to 
synthesize allylic silanes, the synthesis of these compounds have intrigued the community 
for decades. In 1991, Panek and coworkers reported a series of papers on the Claisen 
rearrangement of chiral vinyl silanes to optically pure α-chiral-β-silyl-(E)-hexanoic acids 
(38).19,20 The diastereoselectivity of the products could be altered by changing the reaction 
conditions, strongly favoring either the syn (39) or anti (40) products (Figure 12). Their 
methodology was able to tolerate silyl groups of various steric demands, as well as various 
functional groups at the second stereocenter on the molecule. Product yields using this 
method were quite good, ranging from 55-95%. However, the reaction was somewhat 
limited as all products contained either a terminal ester or acid group, and all products were 




















Figure 12. Synthesis of chiral silyl hexanoic acids via a Claisen rearrangement. 
 
With the lack of a relatively generalized synthesis of these allylic silane reagents, 
the Ito group later reported on a method to diastereoselectively convert chiral allylic 
alcohols to allylic silanes via a disilanyl ether intermediate (Figure 13).21 By first reacting 
the allylic alcohol with 1-chloro-1,1,-dimethyl-1,1,2-triphenyldisilane (42), they were able 
to access a silyl ether (43) that could undergo an intramolecular cyclization using catalytic 
amounts of 1,1,3,3,-tetramethylbutyl isocyanide and palladium acetylacetate. The silicon-
oxygen bonds on the heterocyclic intermediate (44) were cleaved through used of an 
organolithium reagent, affording  chiral allylic silane products (45) with good yields and 
excellent enantioselectivity. This bis-silylation methodology allowed for access to a wide 
variety of aliphatic allylic silane products. However, the use of strong organometallic 
reagents limits the functional group tolerance of this reaction.  
 
 












































Due to challenges in the synthesis of these compounds, such as poor functional 
group compatibility, work continued on developing new methods to construct these allylic 
silanes. Shortly after Ito’s work, the Woerpel group reported on the use of various silver 
and copper catalysts for silylene insertions into carbon-oxygen bonds in order to produce 
chiral allylic silanes (Figure 14).22 Depending on the catalyst and substrate used, they were 
able to access dilanes in addition to allylic silanes. Starting from optically pure allylic 
alcohols (46), they are able to produce the desired allylic silanes (48) in moderate yields 
(63-74%) but with severe erosion of enantioselectivity (36% ee).  
 
 
Figure 14. Silylene insertion of allylic ethers to chiral allylic silanes. 
 
1.7.2 STEREOSELECTIVE APPROACHES 
The previous methods all leverage the chirality of the starting material in order to 
produce enantioenriched allylic silanes through stereospecifc transformations. Recently, 
efforts have focused on using chiral catalysts in order to set the stereocenters of the 
molecule using stereoselective approaches. In the past few decades, there have been 
numerous metal catalysts used to perform silicon-hydrogen insertion of vinylcarbenoids.23 
Davies and coworkers reported some of this asymmetric methodology in 1997. Through 
use of a rhodium (II) propionate catalyst (51), they were able to convert 


















ee) and high yields (63-77%).24 The silyl group is introduced through use of 




Figure 15. Use of rhodium (II) catalyst to form chrial allylic silanes. 
 
In 2010, Wu, Chen, and Panek elaborate on the work of Davies by developing 
copper(I) catalysts to prepare chiral allylic silanes from similar vinyldiazomethane (53) and 
dimethylphenylsilane (54) starting materials.25 These copper catalysts tend to provide the 
products in decreased yields (44-55%) and with lower levels of enantioselectivity (70-
78%), but they can be run at higher temperatures (0 °C) in comparison to the same 
reactions with the rhodium catalyst (–78 °C). They are able to further elaborate these allylic 
silane products (55) via an allylation reaction to obtain products (56) in excellent yields 
(61-88%) but with moderate diastereoselectivity (Figure 16).  
 
 
Figure 16. Use of copper(I) catalyst to synthesize chiral allylic silanes, which can be 










































Copper catalysts continued to be investigated for their use in setting stereocenters 
on allylic silanes. Kacpryznski and coworkers reported a method which uses copper 
catalysts to perform asymmetric alkylation reactions using silyl-substituted unsaturated 
phosphates.26 This reaction differs from the previously mentioned metal-catalyzed 
syntheses of allylic silanes, as its method does not hinge upon the formation of carbon-
silicon bonds to form the stereogenic center. Instead, aryl or alkyl substitution to the silyl-
substituted carbon (57) provides for a route with which tertiary and quaternary silyl-
substituted carbons can be formed from secondary or tertiary silyl-substituted carbons, 
respectively (Figure 17). This methodology uses a chiral N-heterocyclic carbene ligand 
(converted to copper-based catalysts generated in situ with a copper salt) in conjugation 
with an organozinc reagent in order to form chiral allylic silanes (58) with excellent 
enantioselectivity. The shortcoming of this procedure is that it requires the starting material 
to already have a silyl group on the molecule. This lack of modularity prevents this reaction 




Figure 17. Allylic substitution reaction with a copper catalyst generated in situ to 









R1 = H, Me
58




1.8 CROSS-COUPLING AS A MODULAR APPROACH TO CHIRAL 
ALLYLIC SILANES  
Cross-coupling methodology can also be used to synthesize the chiral allylic silane 
compounds prepared by Kacprzynski and coworkers. However, this approach which sets 
the sp3 stereogenic center in a direct carbon-carbon bond formation has the benefit of 
allowing for more modularity when synthesizing allylic silanes. The cheap, simple starting 
materials can be easily modified prior to the cross-coupling in order to produce a wide 
variety of substituted allylic silanes. The first synthesis of enantioenriched chiral allylic 
silanes was reported in 1982 through a cross-coupling reaction developed by Kumada et al. 
(Figure 18).27 Kumada employed the use of a ferrocenyl-palladium complex to promote 
catalysis and the fidelity of the olefin substitution is retained. This reaction is not only 
important due to its ability to form the allylic silane products (61) with high levels of 
enantioselectively, but it is also important due to its lack of E-Z isomerization of the olefin.  
 









R1 R2 % Yield
Me 38 24
Ph H 93 95




















Kumada further elaborated his work by demonstrating the first stereoselective 
Sakurai allylation using these enantioenriched allylic silanes. His work helped elucidate the 
acyclic linear diastereomeric transition states of the allylation reaction, where disfavored 
steric interactions lead to the formation of products with high levels of diastereoselectivity. 
The anti-selectivity of this reaction can be explained through an acyclic linear transition 
state (62 and 63), which minimizes steric interactions between the bulky alkyl groups 
(Figure 19). In this study, allylic silanes with E olefin configuration (61) were observed to 
consistently have good yields and excellent enantioselectivity when forming the 
homoallylic alcohol products (Figure 20).28 Despite the novelty of Kumada’s approach to 
synthesizing chiral allylic silanes, the utility of his method utilized a Grignard reagent in 




Figure 19. Newman projections show the minimizing of gauche interactions in 
Kumada’s allylation. 
 
Organomagnesium halides, such as the magnesium bromide group in Kumada’s 
reaction, are highly reactive and exhibit limitations in functional group compatibility. 
Additionally, Grignard reagents are both air and water sensitive and often are not amenable 
























silanes have used this cross-coupling approach to set the Csp3 stereocenter, possibly due to 
the use of sensitive Grignard reagents.  
 
 
Figure 20. Kumada’s Sakurai allylation.  
 
In order to overcome this shortcoming, the Reisman group was able to develop a 
nickel-catalyzed asymmetric reductive alkenylation reaction to afford chiral allylic silanes 
(68 and 70).29 This method allows for the use of stable electrophiles as both coupling 
partners and alleviates the need for sensitive organometallic reagents (Figure 21). This 
particular method was realized following the development of related nickel-catalyzed 
alkenylations, first between vinyl and benzyl electrophiles (66 and 67) and later between N-
hydroxyphthalimide esters (69) with vinyl bromides (67).30,31 Through use of a manganese 
as a reducing agent which can turn over the nickel catalytic cycle, allows two electrophilic 
components to be cross-coupled, minimizing any typical issues found with nucleophilic 
reagents, such as cost, stability, and somewhat uncontrolled reactivity. Nickel, as a group 
10 metal, does exhibit much of the same reactivity as palladium, however it can access 
more oxidation states which leads to a wider variety of potential mechanistic pathways. 







R1 R2 % Yield
Me
Me Me 82 86

















palladium catalytic cyclic typically only undergoes redox reactions between the 0 and +2 
states. Given its ability to access odd oxidation states, nickel can also participate in a 
variety of radical mechanisms, unlike palladium.32 Overall, nickel is a much more reactive 
and economical catalyst choice, however tuning this reactivity to afford desired reaction 
products in place of undesired side products becomes the main challenge in optimizing 
nickel-catalyzed cross-coupling reactions.  
 
 
Figure 21. Selected nickel-catalyzed reductive cross-coupling methods developed by 
the Reisman group. 
 
The synthesis of chiral allylic silanes by enantioselective nickel-catalyzed reductive 
cross-coupling proceeded in good yield only in the presence of a cobalt (II) phthalocyanine 
co-catalyst (Figure 22). This reagent promotes alkyl radical generation, which more than 
doubles the yield of the desired product in comparison to reactions run without the co-
catalyst.29 They hypothesize that the steric demands of the bulky silyl group disfavors 
oxidative addition of the silyl-substituted benzyl chloride coupling partner (71) to the 
nickel catalyst. The developed reaction conditions are mild and can tolerate a wide variety 
of functional groups, showcasing the versatility of this methodology (Figure 23). The 























work, as chiral allylic silanes with pendant electrophiles can be synthesized using these 
procedures. We envisioned that these novel allylic silane products could be elaborated to 
more challenging heterocyclic motifs common in natural products.   
 
 
Figure 22. Reisman’s asymmetric cross-coupling method to afford chiral allylic silanes 
under mild conditions. 
 
 





































































Reaction Design and Results 
 
2.1 CONCEPTION AND BASIS FOR REACTIVITY 
Recent efforts in the Reisman group have focused on new asymmetric reductive 
cross-coupling methods, as discussed in Chapter 1.8. Reaction conditions to synthesize 
chiral arylated alkenes have been modified to handle a rather sterically demanding regent, a 
silyl substituted benzyl chloride (71). Cross-coupling between this reagent and a vinyl 
bromide (69) can produce chiral allylic silanes (74) with high yields and excellent 
enantioselectivity (Figure 24). More importantly, these cross-coupling conditions can 
tolerate vinyl bromides including pendant electrophiles such as alkyl chlorides, bromides, 
and tosylates. We envisioned these allylic silanes containing terminal electrophilies to be 







Figure 24. Asymmetric reductive cross-coupling between silyl substituted benzyl 
chlorides and vinyl bromides to provide access to chiral allylic silanes. 
 
With this research, we sought to design a new cyclization reaction to aid in the 
construction of complex bioactive natural products, particularly those with heterocyclic 
motifs. Many natural products and pharmaceutical drug candidates contain five- and six-
membered rings with oxygen and nitrogen incorporation (75-79), some of which exhibit a 
variety of therapeutic effects (Figure 25). These heterocyclic rings can be difficult to 
synthesize, so we aimed to develop a one-pot reaction to afford these chiral scaffolds.  
 
 














































































With the knowledge that the addition of chiral allylic silanes to carbonyl compounds can 
lead to the synthesis of chiral homoallylic alcohols with little to no erosion of 
enantioselectivity, we proposed a novel method for the synthesis of chiral heterocycles with 
oxygen incorporation. Allylic silanes can undergo a Sakurai allylation with a wide variety 
of carbon electrophiles. This allylation reaction is stereospecific and highly 
diastereoselective, providing two stereocenters in the product (Figure 26a).28 Additionally, 
it is known that base-mediated SN2 cyclization reactions can occur intramolecularly 
between alcohols with pendant electrophiles in order to form tetrahydropyrans (Figure 
26b).33 The aim of this research was to combine these two fundamental principles and 
develop a one-pot procedure to convert chiral allylic silanes into chiral heterocyclic 
products through a tandem allylation/cyclization approach (Figure 26c). 
 
 


































Starting from chiral allylic silanes, we propose that cyclization to heterocyclic five- 
and six-membered heterocyclic rings can be achieved. The cross-coupling of vinyl 
bromides and benzyl chlorides yields chiral allylic silanes,29 which can undergo Lewis 
acid-catalyzed allylations with aldehydes. With these allyation products, the homoallylic 
alcohols are observed. We proposed that isolation of the chiral homoallylic alcohol could 
be avoided. Instead, intramolecular cyclization with a pendant electrophile, initially 
synthesized on a vinyl bromide coupling partner, could be achieved in one step during this 
reaction (Figure 27). 
 
 
Figure 27. Proposed synthesis of tetrahydropyrans from allylic silanes. 
 
2.2 INITIAL SCREENING OF LEWIS ACIDS 
While the Sakurai allylation can be performed with either catalytic or 
stoichiometric amounts of Lewis acid, the majority of examples in the literature utilize 
stoichiometric quantities. Each molecule of Lewis acid will activate the electrophile to 
promote the allylation reaction via coordination to the oxygen atom of the carbonyl group. 
Thus, we began our investigations with stoichiometric amounts of Lewis acids in attempts 

















Figure 28. Preliminary screening of allylic silane with pendant electrophile with two 
Lewis acids commonly used in the Sakurai allylation. 
 
Initial screening attempts investigated the use of an allylic silane with a pendant 
tosylate electrophile (88). Typical Kumada allylation conditions were employed and  two 
different Lewis acids were tested: boron trifluoride diethyl etherate and titanium 
tetrachloride. Monitoring the reaction by thin layer chromatography (TLC), boron 
trifluoride etherate did not show significant consumption of the starting material at –78 °C, 
and it was not until the reaction reached room temperature that other products began to 
form. Four products, in addition to the starting material, were collected by preparatory 
TLC, however none had the predicted retention factor (Rf) for the desired cyclized product. 
Of these four products, proton nuclear magnetic resonance spectroscopy (1H NMR) 
confirmed that the desired cyclization did not occur, as the two major products still had the 
tosylate group on the molecule. Liquid chromatography-mass spectrometry (LCMS) was 
used to analyze these two products to determine if either was the allylated alcohol 
intermediate, however the obtained masses (452 g/mol and 557 g/mol) did not align with 
this intermediate.  
When the reaction was conducted with titanium tetrachloride as the Lewis acid, we 
observed a new major product by TLC when the reaction was cooled to –78 °C. This 

















trifluoride diethyl etherate, warming the reaction to room temperature also resulted in four 
products were also collected by preparatory TLC, however LCMS confirmed that none of 
the products were from the desired cyclization. Furthermore, the alcohol intermediate 
decomposed once the reaction had warmed to room temperature, so we evaded the issue by 
running the reaction again and quenching with water at –78°C.  
With this information in hand, we set out to quantify the amount of our alcohol 
intermediate. The general protocol used 1.1 equivalents of titanium chloride in 
dichloromethane at –45 °C, the lowest temperature available in the glovebox cryocool. The 
model substrates we investigated included propionaldehyde and an allylic silane with a 
pendant chloride electrophile (this allylic silane proved more amenable to scale up to 
multigram scale). The reaction was quenched with water prior to warming to room 
temperature, which alleviated decomposition of the alcohol. Gas chromatography (GC) was 
used to quantify the product yields, which provided 69% yield of the alcohol intermediate 
and 2% yield of the desired tetrahydropyran product. With the alcohol intermediate in 
hand, a formal synthesis via Perrott’s conditions could allow access to the heterocycle, 
however a reaction using a one pot procedure would be ideal. Thus, we conducted a GC 


















2.3 SCREENING OF ADDITIVES TO PROMOTE CYCLIZATION 
Given the low 2% yield of the tetrahydropyran, we proposed two hypotheses for 
lack of cyclization. First, we proposed that the coordination of titanium to the alkoxide 
prohibited intramolecular cyclization. Second, we suggested that the reaction conditions 
were too acidic, and rapid protonation of the alkoxide intermediate inhibitied cyclization to 
the heterocycle.  
In order to test these two hypotheses, we screened different additives and analyzed 
the results with our GC assay. The allylation reaction was conducted at –78 °C for two 
hours, and then an additive was used to promote cyclization at room temperature. Initially, 
a crown ether was added to see if coordination between titanium and oxygen was inhibiting 
cyclization to occur. We proposed that the crown ether would coordinate the titanium and 
displace the alkoxide. Thus would allow for the oxygen atom to attack the carbon alpha to 
the pendant electrophile via an SN2 cyclization. With the addition of benzo-15-crown-5, 
limited cyclization (1% yield) was observed (Figure 30).  
 
 
Figure 30. Proposed mechanism for crown ether additive to promote cyclization. 
 
We then tested our second hypothesis by adding base to the reaction mixture with 


















31).  With the addition of a mild base, 2,6-lutidine (95), the desired tetrahydropyran was 
only observed in a 2% yield. There was no improvement from the addition of either a 
crown either or mild base compared to runs without any additives.  
 
 
Figure 31. Proposed mechanism for mild base to promote cyclization. 
 
Potassium tert-butoxide was then explored as a stronger base. When one or two 
equivalents were added to the reaction, minimal cyclization occurred (2% yield). However 
with five equivalents of potassium tert-butoxide, the reaction successfully produced the 
desired tetrahydropyran: only 1% yield of the alcohol was remaining and 69% yield of the 
desired product was obtained. This suggests that the issue with cyclization may be related 
to the displacement of the chlorides from titanium while it is coordinated to the oxygen 
atom (Figure 32). If the remaining three chlorides can be displaced, titanium can dissociate 
from the oxygen atom with a fourth equivalent of base and produce the desired cyclic 
product (90). Should this be the case, only four equivalences of potassium tert-butoxide are 
necessary to induce cyclization.  
With this knowledge of the proposed mechanism, we briefly attempted to make the 
reaction catalytic. Instead of using titanium tetrachloride as the Lewis acid, we attempted to 
use titanium isopropoxide. This Lewis acid already has bulky alkoxide groups coordinated 
to the titanium which could render the reaction catalytic by recycling the Lewis acid in the 










equivalents) amounts of titanium isopropoxide, the reaction failed to yield any allylated 
product and only starting material was recovered. 
 
 
Figure 32. Proposed mechanism for cyclization with four equivalents of strong base. 
 
2.4 APPLYING THE METHOD TO TETRAHYDROFURANS 
Although our initial investigations with this new method focused primarily on the 
synthesis of tetrahydropyrans, we transitioned to synthesizing tetrahydrofurans for the latter 
half of the project. Ito and coworkers report on the use of allylic silanes in order to 
synthesize 2,3-disubstituted cyclic ethers through an intramolecular cyclization via an 
oxonium ion intermediate (Figure 33).34 More specifically, they are able to construct 
enantioenriched tetrahydropyrans with anti-stereochemistry between the two adjacent 
stereocenters. With their tetrahydrofuran products, only syn stereochemistry is observed 






























































advantageous for us to focus our efforts in producing tetrahydrofurans with trans 
substitution as there are limited methods in the literature to synthesize these product 
scaffolds. Our methodology produces trans-substituted cyclic ethers regardless of ring size 
with excellent diastereoselectivity, so we focused our studies on the construction of 2,3-
disubstituted tetrahydrofurans. In order to prepare the required allylic silane starting 
material, we performed the nickel-catalyzed cross-coupling with a vinyl bromide 
containing one less methylene group than in our previous methods. With the allylic silane 
in hand, we could begin our efforts to optimize the reaction to benchtop procedures such 
that it can be a practical and broadly accessible method.  
 
 
Figure 33. Ito’s method involves a cyclic transition state to afford heterocycles. 
 
2.5 A MORE EFFICIENT ROUTE TOWARD ALLYLIC SILANE 
REAGENTS 
The original route the allylic silane starting material provided limitations to 
scalability (Figure 34). In order to synthesize the desired allylic silane containing a pendent 
chloride electrophile, we proceed through a four-step route. The cross-coupling step at the 















>20:1 dr, 1:1 E:Z
99
n=3, quant. yield















approximately a 70% yield by NMR, only a 40% yield of 91 can be isolated due to a 
difficult, greasy separation of numerous side products. In fact, it takes 20 liters of hexanes 
in one column to isolate ~1 g of clean material. In order to access large amounts of material 
to optimize a generalized benchtop procedure, we investigated an alternate route to allylic 
silane 106 with great success. 
 
 
Figure 34. Original route to allylic silane starting material. 
 
Although we targeted the lowest yielding substrate in the allylic silane cross-
coupling method (pendant alcohol 107),29 the NMR yield and isolated yield were 
comparable at 48% and 45%, respectively. More importantly the ability to purify the allylic 
silane 107 was much easier than allylic silane 106, as it only required 2.5 L of solvent in 
order to obtain ~3 g of material. A subsequent Appel chlorination provided 96% yield of 
the desired product (106). This route is significantly easier to perform on large scale to 
produce sufficient starting material for the tandem allylation/cyclization reaction. While the 
cross-coupling method leaves room for improvement (a low 45% yield was obtained), at 
the onset, we are able to isolate sizable quantities of allylic silane reagent, which speeds up 























Figure 35. Improved route to allylic silane starting material. 
  
2.6 MODIFICATIONS TO A GENERALIZED BENCHTOP 
PROCEDURE 
With a successful method in hand, efforts turned to adapting the protocol to a 
benchtop setup. The desired tetrahydropyran could be produced using the proposed tandem 
allylation/cyclization method, however, the conditions required the allylation step to be 
performed for one hour at –45 ºC in a glovebox followed by cyclization at room 
temperature for two hours. In order to make this chemistry broadly accessible, we 
proceeded to optimize this methodology with common setup conditions by avoiding the 
need for a glovebox and a cryocool. We sought to modify the procedure such that it could 
be performed on a benchtop without any specialized equipment under common reaction 
conditions (e.g. –78 ºC with a dry ice and acetone bath).  
Initially, the allylation portion of the cascade reaction was allowed to proceed for a 
1 hour at –45 ºC. Literature precedent on the Sakurai allylation described relatively short 
reaction times (0.5-10 minutes) at lower temperatures (–78 ºC) which could afford the 
desired homoallylic alcohol in high yields. However, our efforts to modify the tandem 
reaction sequence on the benchtop while using these new conditions coincided with a 
significant decrease in the conversion rate of the allylic silane (Figure 36). 1H NMR was 














and the allylated alcohol product. Based on these results, we believed that a problem had 
arisen in the reaction when conducted on the benchtop. As a result, particular emphasis was 
placed on optimizing the allylation step in order to regain good conversion and increase the 





Figure 36. 1H NMR of benchtop allylation setup shows low amounts of desired 
product (HA/HB) and low conversion of the allylic silane starting material (HC/HD). 
 
We proposed that the low conversion was most likely a result of adventitious water 
in the reaction. Since the reaction conditions use stoichiometric titanium tetrachloride,  one 
would predict that the starting material should be completely consumed, either to the 




material was able to survive such harsh Lewis acidic conditions, we believed that 
fortuitous water was quenching the titanium tetrachloride. Once the alcohol was formed, 
indeed a large excess of strong base funneled the intermediate to the cyclic product. 
Consequently, the majority of our optimization efforts focused on remedying the allylation 
step.  
Various parameters were investigated in order to modify our method to a 
generalized benchtop procedure with good conversion and high yields. To ensure purity of 
the regents prior to the reaction, either newly purchased aldehyde reagents or freshly 
distilled regents were used to ensure clean material. This purification became vital to the 
new standard setup conditions. To rid the reaction of adventitious water, the flask was 
purged with argon gas and 3 Å molecular sieves were added to the reaction in order to 
maintain dry reaction conditions. With these modifications, the allylation step could be 
conducted at –78 °C in only 10 minutes.  Brief investigations on the cyclization portion of 
the cascade involved varying the equivalents of base used and altering the counterion of the 
base from potassium to lithium. In summary we found that this combination of these 
conditions restored reactivity and allowed for access to the desired heterocyclic products on 
the benchtop in good yields: use of argon atmosphere, addition of molecular sieves, 10 
minute allylation time at –78 ºC, and use of 10 equivalents of potassium tert-butoxide for 
cyclization. 
During these optimization studies, it also became readily apparent that the quality 
of the titanium tetrachloride played a large role in the success of the initial allylation step of 
the cascade reaction. Both argon and molecular sieves had to be utilized in the new method 




Lewis acid. Additionally, if sure-sealed bottles of titanium tetrachloride solution were a 
few weeks old and stored on the benchtop, notable decreases in yield (on the order of 10-
20% less) were observed. Since buying a new reagent every month was not economical, we 
sought to better understand the degradation of the Lewis acid via a brief study. When 
comparing a new bottle, a handmade solution from neat titanium tetrachloride (stored in the 
glove box), and a several week old bottle that was stored in the glove box in between uses, 
we found that as long as the solution is stored under inert atmosphere in a glove box, the 
age of the titanium tetrachloride solution does not matter. 
 
2.7 SUBSTRATE SCOPE 
With a successful tandem allylation/cyclization procedure now available, we moved 
forward to expand the substrate scope. As mentioned previously, according to a known 
procedure by Ito and coworkers, allylic silanes with pendant electrophiles can converted to 
the cis diasteromer of the tetrahydrofuran. However, with our optimized reaction 
conditions, we can access the trans diastereomer of the tetrahydrofuran. In order to fully 
demonstrate the utility of these allylic silane reagents, we decided to pursue the substrate 
scope on both the cis and trans diastereomers to investigate interesting differences between 
the two methods (Figure 37).  
In our initial screen of various aldehydes, we were able to successfully synthesize 
both diastereomers of six different tetrahydrofurans. Four possible products can be 
obtained in this method, resulting from the cis and trans configuration of the adjacent 




is given for the cis/trans ratio, the E:Z olefin ratio, and the percentage of the major isomer 
out of the four possible products. When analyzing the substrate scope, we note several 
interesting observations resulting from differences in the two reaction mechanisms. The Ito 
 
 
Figure 37. Substrate scope of the two diastereomers of the tetrahydrofuran products. 
 
reaction proceeds through an intramolecular allylation and universally gives higher yields 
compared to the intermolecular approach. Conversely, the tandem allylation/cyclization 
method developed in this work proceeds through a linear transition state and is influenced 
heavily by the sterics of the molecule. This is evident in comparing the yields of the two 









































































































isopropyl group, the yield does not change using the condensation/intramolecular 
allylation route – 98% with 110 versus 99% with 111. However, when comparing the same 
aldehydes with the tandem allylation/cyclization method, the yield decreases significantly 
from 86% with 112 to 79% with 113. The same steric argument contributes to the moderate 
yields of using cyclohexane as the R group, although further investigations on using 
various ring sizes suggest there is more at play in this mechanism. 
Another interesting observation reveals that allylations with the aldehyde 
containing a pendant chloride electrophile have excellent yields with both methods. This 
shows that additional pendant electrophiles can be tolerated under the reaction conditions 
(versus eliminating to form a terminal olefin) and also provides insight into the cyclization 
step. With 5-chloropentanal, the alkoxide intermediate could cyclize onto the pendent 
electrophile of the aldehyde, rather than that of the allylic silane, providing two possible 
products – 120 and 123 (Figure 38). However, via our method, the proposed six-membered 
heterocyclic ring product is not observed. Rather, we saw great success (96% yield of 120) 
using a long chain with a pendant chloride as the R group on the aldehyde. This provides 
interesting insight into the kinetics of the cyclization, as the five-membered heterocyclic 
ring was preferentially formed. 
 
 














Additionally, we note that that aldehydes containing benzyl ether moieties have a 
drastic effect on the observed diastereomeric ratio (dr). With the tandem 
allylation/cyclization method, tetrahydrofuran 121 was formed with low dr of 2:1. As a 
result, we investigated a series of aldehydes containing benzyl ether functional groups in 
order to investigate coordination effects on the observed d.r. (Figure 39). In order to obtain 
full conversion of starting material, we modified our procedure to use 2.0 equivalents 
titatnium tetrachloride and 15.0 equivalents base. 
 
 
Figure 39. Substrate scope for aldehydes with various pendant benzyl ether groups. 
 
In the case of the trans-2,3-tetrahyrofurans, the dr between the trans to cis 
diastereomers improves as the benzyl group distance from the aldehyde increases. 
Interestingly, as with tetrahydrofuran 127, the benzyl group inverts the selectivity giving 
the cis product as the major diastereomer. According to Judd and coworkers, a benzyl ether 
group can stabilize intermediates and have effects on diasteromeric control.35 In this case, 






































































transition state and leads to erosion of diastereoselectivity. The benzyl group does not 
become non-innocent in this transformation until four methylene units are incorporated in 
the aldehyde as seen in tetrahydrofuran 129. In contrast, the diastereoselectivity of the cis-
2,3-tetrahydrofurans (124-126) is not affected by the presence of the benzyl group. 
 
2.8 CONCLUSIONS AND FUTURE DIRECTIONS  
 We were able to successfully develop a one-pot procedure to synthesize chiral 
tetrahydropyrans from chiral allylic silanes in good yields and with excellent 
diastereoselectivity. This procedure consists of a cascade reaction, starting with a Sakurai 
allyation followed by base-mediated cyclization to afford enantioenriched heterocycles – 
both tetrahydrofurans and tetrahydropyrans. We report on expansion of the substrate scope 
to use various aldehydes as well as studies on the cyclization mechanism and 
diastereoselectivity of the reaction with pendent benzyl ethers. Future work will involve a 
more detailed study into the mechanism of the reaction, as well as testing additional 
aldehyde and ketone substrates. Furthermore, we seek to expand the use of this method 
beyond the synthesis of cyclic ethers and future studies will investigate the formation of 
nitrogen-containing heterocycles via use of an imine in lieu of an aldehyde (Figure 40). 
 
 












































Unless otherwise stated, reactions were performed under a nitrogen atmosphere 
using freshly dried solvents. Methylene chloride (CH2Cl2) was dried by passing through an 
activated alumina column. N-methylpyrrolidinone (NMP), titanium tetrachloride (1.0 M in 
CH2Cl2), and potassium tertbutoxide (1.0 M in THF) were purchased from Sigma Aldrich 
and stored in the glovebox. Manganese powder (–325 mesh, 99.3%) was purchased from 
Alfa Aesar. Unless otherwise stated, chemicals were used as received. All reactions were 
monitored by thin-layer chromatography (TLC) using EMD/Merck silica gel 60 F254 pre-
coated plates (0.25 mm) and were visualized by ultraviolet (UV) light or with potassium 
permanganate (KMnO4) staining. Flash column chromatography was performed as 
described by Still et al.36 using silica gel (230-400 mesh) purchased from Silicycle. Optical 
rotations were measured on a Jasco P-2000 polarimeter using a 100 mm path-length cell at 
589 nm. 1H and 13C NMR spectra were recorded on a Bruker Avance III HD with Prodigy 
cyroprobe (at 400 MHz and 101 MHz, respectively). NMR data is reported relative to 
internal CHCl3 (1H, δ = 7.26) and CDCl3 (13C, δ = 77.1). Data for 1H NMR spectra are 
reported as follows: chemical shift (δ ppm) (multiplicity, coupling constant (Hz), 
integration). Multiplicity and qualifier abbreviations are as follows: s = singlet, d = doublet, 
t = triplet, q = quartet, m = multiplet. IR spectra were recorded on a Perkin Elmer Paragon 
1000 spectrometer and are reported in frequency of absorption (cm–1). Analytical chiral 
SFC was performed with a Mettler SFC supercritical CO2 chromatography system with 
Chiralcel AD-H, OD-H, AS-H, OB-H, and OJ-H columns (4.6 mm x 25 cm). HRMS were 
acquired from the Caltech Mass Spectral Facility using fast-atom bombardment (FAB) or 
electron impact (EI). X-ray diffraction and elemental analysis (EA) were performed at the 






According to a procedure by Reisman and coworkers29, a 250 mL round bottom flask with 
a stir bar was equipped with Mn0 powder (4.95 g, 90 mmol, 3 equiv), cobalt phthalocyanine 
(857 mg, 1.5 mmol, 0.05 equiv), and NiCl2BOX complex (73, 1.455 g, 3 mmol, 0.1 equiv). 
The flask was brought into a N2-filled glovebox, and then the NMP (60 mL, 0.5 M), 
(chloro(phenyl)methyl)trimethylsilane (5.96 g, 30 mmol, 1 equiv), and (E)-4-bromobut-3-
en-1-ol (7.61 g, 45 mmol, 1.5 equiv) were added sequentially. The flask was sealed with a 
new rubber septum, wrapped with electrical tape, and stirred at 5 °C in a cryocool for 6 
days. The crude reaction was diluted with Et2O and H2O, slowly quenched with 1 M HCl, 
and further diluted with water. The aqueous layer was extracted with Et2O and the 
combined organic layers were dried with MgSO4, filtered, and concentrated under reduced 
pressure. The crude material was purified by column chromatography (silica, 1:1:1 
Et2O/hexanes/PhMe) to yield 3.1 g of 107 (45% yield) in 98% ee as a blue oil. Spectral 




Allylic silane (107, 98% ee, 1.6 g, 6.83 mmol, 1 equiv), triphenylphosphine (2.685 g, 10.2 
mmol, 1.5 equiv), carbon tetrachloride (1.32 mL, 13.7 mmol, 2 equiv), and DCM (7 mL, 
0.98 M) were added to a 25 mL round bottom flask equipped with a stir bar. The reaction 


















mixture was refluxed under a N2 atmosphere at 40 °C for 1 day. The crude reaction mixture 
was loaded directly onto a silica plug and flushed with 250 mL hexanes to afford 1.66 g of 
106 (96% yield) in 98% ee as a colorless oil. Spectral data matched those reported in 
literature.29 
 
General Procedure 1: Allylation/Cyclization for trans-2,3-tetrahydrofurans 
 
On a bench-top, a 10 mL round bottom flask equipped with a stir bar was sealed 
with a septum and electrical tape, then flame dried with a propane torch and backfilled with 
argon. Then 100 mg of oven-dried 3 Å molecular sieves were quickly added to the flask, 
which was subsequently evacuated and backfilled with argon. The allylic silane (0.22 
mmol, 1.1 equiv), aldehyde (0.2 mmol, 1 equiv), and anhydrous CH2Cl2 (2.0 mL, 0.1 M) 
were added to the flask via syringe while under an Ar atmosphere. The reaction mixture 
was cooled to –78 °C and TiCl4 solution (0.24 mmol, 1.2 equiv, 1 M in DCM) was added 
via syringe. After stirring for 10 minutes, anhydrous KOtBu solution (2 mmol, 10 equiv, 1 
M in THF) was slowly added to the flask via syringe, the reaction was allowed to warm to 
room temperature, and continued to stir for 2 hours. The crude reaction was filtered through 
a plug of celite (approx. 4 cm in diameter and 1 cm thick), flushed with 50 mL of Et2O, and 
concentrated under reduced pressure. The crude residue was purified by column 
chromatography to yield the desired product. 
 
  
RCHO, TiCl4, 4 Å MS, CH2Cl2, —78 °C









Prepared from (S,E)-(5-chloro-1-phenylpent-2-en-1-yl)trimethylsilane (106, 
55.6 mg, 1.1 equiv, 0.22 mmol, 98% ee) and propionaldehyde (14.4 µl, 1.0 
equiv, 0.2 mmol) according to General Procedure 1. The crude residue was purified by 
column chromatography (silica, 0 to 5% Et2O/hexanes) to yield 34.6 mg of 112 (86% yield, 
>20:1 dr, >20:1 E:Z, 94% major isomer) as a colorless oil. Rf = 0.39 (silica, 10% 
EtOAc/hexane, UV).  [𝒂]𝑫𝟐𝟓	 = +48° (c = 0.5, CHCl3). 
1H NMR (500 MHz, CDCl3): δ 7.40 
– 7.34 (m, 2H), 7.32 (ddd, J = 7.8, 6.7, 1.2 Hz, 2H), 7.25 – 7.20 (m, 1H), 6.45 (d, J = 15.8 
Hz, 1H), 6.12 (dd, J = 15.8, 8.7 Hz, 1H), 3.92 (dd, J = 8.1, 5.9 Hz, 2H), 3.52 (td, J = 7.9, 
4.1 Hz, 1H), 2.62 – 2.51 (m, 1H), 2.19 (ddt, J = 12.0, 8.1, 5.9 Hz, 1H), 1.89 (ddt, J = 12.4, 
9.0, 8.1 Hz, 1H), 1.73 – 1.63 (m, 1H), 1.54 (dt, J = 13.9, 7.4 Hz, 1H), 1.01 (t, J = 7.4 Hz, 
3H). 13C NMR (126 MHz, CDCl3): δ 137.3, 131.0, 130.9, 128.7, 127.6, 126.2, 85.3, 67.3, 
48.9, 33.9, 26.9, 10.8. FTIR (NaCl, thin film, cm-1): 2964, 2932, 2875, 1493, 1450, 1116, 
1020, 965, 746, 693.  
 
(2R,3R)-2-isopropyl-3-((E)-styryl)tetrahydrofuran (113) 
Prepared from (S,E)-(5-chloro-1-phenylpent-2-en-1-yl)trimethylsilane (106, 
55.6 mg, 1.1 equiv, 0.22 mmol, 98% ee) and isobutylaldehyde (18.2 µl, 1.0 
equiv, 0.2 mmol) according to General Procedure 1. The crude residue was purified by 
column chromatography (silica, 0 to 5% Et2O/hexanes) to yield 34.3 mg of 113 (79% yield, 
>20:1 dr, >20:1 E:Z, 94% major isomer) as a colorless oil. Rf = 0.46 (silica, 10% 
EtOAc/hexane, UV).  [𝒂]𝑫𝟐𝟓	 = +46° (c = 1.0, CHCl3). 










– 7.28 (m, 4H), 7.25 – 7.19 (m, 1H), 6.43 (d, J = 15.8 Hz, 1H), 6.14 (dd, J = 15.8, 8.8 Hz, 
1H), 3.93 – 3.83 (m, 2H), 3.45 (dd, J = 7.7, 5.5 Hz, 1H), 2.74 (p, J = 8.2 Hz, 1H), 2.16 
(dddd, J = 12.0, 8.1, 6.6, 5.1 Hz, 1H), 1.92 – 1.77 (m, 2H), 0.98 (dd, J = 6.8, 1.0 Hz, 6H). 
13C NMR (101 MHz, CDCl3): δ 137.4, 132.1, 130.4, 128.7, 127.3, 126.1, 88.9, 67.5, 46.3, 
34.6, 31.8, 19.7, 18.2. FTIR (NaCl, thin film, cm-1): 3026, 2961, 2933, 2872, 1493, 1486, 
1449, 1387, 1071, 1051, 965, 747, 693.  
 
(2R,3R)-2-cyclohexyl-3-((E)-styryl)tetrahydrofuran (117)  
Prepared from (S,E)-(5-chloro-1-phenylpent-2-en-1-yl)trimethylsilane (106, 
55.6 mg, 1.1 equiv, 0.22 mmol, 98% ee) and cyclohexanecarbaldehyde (22.4 
mg, 1.0 equiv, 0.2 mmol) according to General Procedure 1. The crude residue was purified 
by column chromatography (silica, 0 to 5% Et2O/hexanes) to yield 27.1 mg of 117 (53% 
yield, >20:1 dr, 20:1 E:Z, 91% major isomer) as a colorless oil. Rf = 0.42 (silica, 10% 
EtOAc/hexane, UV).  [𝒂]𝑫𝟐𝟓	 = +78° (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ 7.40 
– 7.34 (m, 2H), 7.34 – 7.28 (m, 2H), 7.25 – 7.19 (m, 1H), 6.43 (d, J = 15.7 Hz, 1H), 6.13 
(dd, J = 15.7, 8.8 Hz, 1H), 3.93 – 3.79 (m, 2H), 3.44 (dd, J = 7.6, 5.7 Hz, 1H), 2.78 (p, J = 
8.2 Hz, 1H), 2.19 – 2.09 (m, 1H), 1.85 (dq, J = 12.3, 7.8 Hz, 2H), 1.79 – 1.69 (m, 3H), 1.68 
– 1.61 (m, 1H), 1.49 (tdt, J = 11.7, 6.1, 3.3 Hz, 1H), 1.30 – 1.04 (m, 5H). 13C NMR (101 
MHz, CDCl3): δ 137.5, 132.1, 130.3, 128.7, 127.3, 126.1, 88.3, 67.4, 46.0, 41.9, 34.6, 
30.1, 28.7, 26.7, 26.5, 26.3. FTIR (NaCl, thin film, cm-1): 2925, 2852, 1492, 1449, 1085, 







(2R,3R)-2-(4-chlorobutyl)-3-((E)-styryl)tetrahydrofuran (120)  
Prepared from (S,E)-(5-chloro-1-phenylpent-2-en-1-yl)trimethylsilane 
(196, 55.6 mg, 1.1 equiv, 0.22 mmol, 98% ee) and 5-chloropentanal (24 
µl, 1.0 equiv, 0.2 mmol) according to General Procedure 1. The crude residue was purified 
by column chromatography (silica, 0 to 6% Et2O/hexanes) to yield 48.6 mg of 120 (92% 
yield, 15:1 dr, >20:1 E:Z, 91% major isomer) as a colorless oil. Rf = 0.36 (silica, 10% 
EtOAc/hexane, UV).  [𝒂]𝑫𝟐𝟓	 = +64° (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ 7.40 
– 7.28 (m, 4H), 7.25 – 7.20 (m, 1H), 6.46 (d, J = 15.8 Hz, 1H), 6.10 (dd, J = 15.7, 8.8 Hz, 
1H), 3.95 – 3.88 (m, 2H), 3.59 – 3.50 (m, 3H), 2.60 – 2.49 (m, 1H), 2.20 (dddd, J = 12.0, 
8.1, 6.4, 5.3 Hz, 1H), 1.94 – 1.85 (m, 1H), 1.85 – 1.75 (m, 2H), 1.70 – 1.62 (m, 2H), 1.57 – 
1.47 (m, 2H). 13C NMR (101 MHz, CDCl3): δ 137.2, 131.3, 130.5, 128.7, 127.4, 126.2, 
83.7, 67.3, 49.4, 45.1, 33.8, 33.2, 32.8, 24.1. FTIR (NaCl, thin film, cm-1): 2938, 2867, 
1492, 1449, 1071, 1029, 1017, 966, 748, 693. 
 
(2R,3R)-2-(but-3-en-1-yl)-3-((E)-styryl)tetrahydrofuran (116) 
Prepared from (S,E)-(5-chloro-1-phenylpent-2-en-1-yl)trimethylsilane 
(106, 55.6 mg, 1.1 equiv, 0.22 mmol, 98% ee) and pent-4-enal (16.8 mg, 
1.0 equiv, 0.2 mmol) according to General Procedure 1. The crude residue was purified by 
column chromatography (silica, 0 to 5% Et2O/hexanes) to yield 26.5 mg of 116 (58% yield, 
10:1 dr, >20:1 E:Z, 89% major isomer) as a colorless oil. Rf = 0.39 (silica, 10% 
EtOAc/hexane, UV).  [𝒂]𝑫𝟐𝟓	 = +69° (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ 7.40 









(dd, J = 15.8, 8.8 Hz, 1H), 5.84 (ddt, J = 16.8, 10.1, 6.6 Hz, 1H), 5.09 – 4.92 (m, 2H), 3.97 
– 3.89 (m, 2H), 3.58 (td, J = 8.3, 3.7 Hz, 1H), 2.56 (p, J = 8.2 Hz, 1H), 2.35 – 2.10 (m, 3H), 
1.89 (ddt, J = 12.3, 9.0, 8.1 Hz, 1H), 1.73 (dddd, J = 13.7, 10.0, 6.2, 3.7 Hz, 1H), 1.60 
(dddd, J = 13.8, 9.7, 8.1, 5.3 Hz, 1H). 13C NMR (101 MHz, CDCl3): δ 138.6, 137.3, 
131.2, 130.6, 128.7, 127.4, 126.2, 114.7, 83.4, 67.3, 49.5, 33.9, 33.4, 30.8. FTIR (NaCl, 
thin film, cm-1): 3026, 2974, 2931, 2868, 1640, 1493, 1449, 1071, 966, 911, 747, 693.  
 
(2S,3R)-2-((benzyloxy)methyl)-3-((E)-styryl)tetrahydrofuran (127)  
Prepared from (S,E)-(5-chloro-1-phenylpent-2-en-1-yl)trimethylsilane (106, 
55.6 mg, 1.1 equiv, 0.22 mmol, 98% ee) and 2-(benzyloxy)acetaldehyde 
(30.0 mg, 1.0 equiv, 0.2 mmol) according to General Procedure 1 with the exception that 
2.0 equivalents TiCl4 and 15.0 equivalents KOtBu were used in this procedure. The crude 
residue was purified by column chromatography (silica, 0 to 20% Et2O/hexanes) to yield 
44.2 mg of 127 (75% yield, 1:3 dr (Note: trans is the minor diastereomer), >20:1 E:Z, 24% 
major isomer) as a yellow oil. Rf = 0.18 (silica, 10% EtOAc/hexane, UV).  [𝒂]𝑫𝟐𝟓	 = +41° (c 
= 1.0, CHCl3). 1H NMR (400 MHz, CDCl3): Note: mixture of diastereomers, contains 
additional impurity: δ 7.39 – 7.16 (m, 10.00H), 6.50 – 6.34 (m, 0.74H), 6.25 – 6.07 (m, 
0.75H), 4.68 – 4.46 (m, 1.88H), 4.18 – 4.03 (m, 1.36H), 4.01 – 3.92 (m, 0.42H), 3.92 – 
3.79 (m, 0.94H), 3.66 (dd, J = 10.5, 2.9 Hz, 0.24H), 3.63 – 3.46 (m, 1.87H), 3.44 – 3.32 (m, 
0.51H), 3.08 (dq, J = 9.4, 6.9 Hz, 0.57H), 2.80 (p, J = 8.5 Hz, 0.15H), 2.63 (dddt, J = 7.2, 
4.3, 2.9, 1.4 Hz, 0.19H), 2.19 (dtd, J = 12.5, 7.6, 4.9 Hz, 0.74H), 2.03 – 1.85 (m, 0.83H). 






impurity: δ 138.25, 137.19, 131.33, 131.07, 130.05, 128.74, 128.56, 128.51, 128.35, 
128.33, 128.27, 127.73, 127.65, 127.56, 127.52, 127.37, 127.29, 126.16, 126.11, 80.81, 
73.52, 70.99, 70.96, 67.93, 67.67, 45.23, 45.20, 36.24, 33.57, 32.81, 28.68, 27.59. FTIR 
(NaCl, thin film, cm-1): 3027, 2973, 2930, 2866, 1495, 1452, 1364, 1197, 1092, 1028, 
969, 748, 696.  
 
(2R,3R)-2-(2-(benzyloxy)ethyl)-3-((E)-styryl)tetrahydrofuran (121) 
Prepared from (S,E)-(5-chloro-1-phenylpent-2-en-1-yl)trimethylsilane 
(106, 55.6 mg, 1.1 equiv, 0.22 mmol, 98% ee) and 3-(benzyloxy)propanal 
(32.8 mg, 1.0 equiv, 0.2 mmol) according to General Procedure 1 with the exception that 
2.0 equivalents TiCl4 and 15.0 equivalents KOtBu were used in this procedure. The crude 
residue was purified by column chromatography (silica, 0 to 15% Et2O/hexanes) to yield 
35.7 mg of 121 (58% yield, 2:1 dr, >20:1 E:Z, 63% major isomer) as a pale yellow oil. Rf = 
0.18 (silica, 10% EtOAc/hexane, UV).  [𝒂]𝑫𝟐𝟓	 = +38° (c = 1.0, CHCl3). 
1H NMR (400 
MHz, CDCl3): Note: mixture of diastereomers: δ 7.39 – 7.19 (m, 10H), 6.51 – 6.32 (m, 
1H), 6.23 – 6.04 (m, 1H), 4.58 – 4.42 (m, 2H), 4.10 – 3.98 (m, 0.7H), 3.97 – 3.88 (m, 
1.2H), 3.81 (td, J = 8.4, 6.7 Hz, 0.4H), 3.76 – 3.52 (m, 3H), 3.36 (t, J = 6.3 Hz, 0.3H), 3.01 
– 2.90 (m, 0.3H), 2.59 (p, J = 8.4 Hz, 0.6H), 2.29 – 2.13 (m, 1H), 2.05 – 1.92 (m, 0.7H), 
1.92 – 1.75 (m, 2.3H). 13C NMR (101 MHz, CDCl3): Note: mixture of diastereomers: δ 
138.63, 137.35, 137.25, 131.35, 131.08, 130.28, 129.46, 128.67, 128.47, 128.45, 127.83, 
127.79, 127.64, 127.60, 127.41, 127.35, 126.22, 81.05, 79.21, 73.21, 73.18, 68.04, 67.91, 







film, cm-1): 3027, 2969, 2930, 2865, 1495, 1453, 1363, 1198, 1099, 1028, 967, 748, 696.  
(2R,3R)-2-(3-(benzyloxy)propyl)-3-((E)-styryl)tetrahydrofuran (128)  
Prepared from (S,E)-(5-chloro-1-phenylpent-2-en-1-yl)trimethylsilane 
(106, 55.6 mg, 1.1 equiv, 0.22 mmol, 98% ee) and 4-(benzyloxy)butanal 
(35.6 mg, 1.0 equiv, 0.2 mmol) according to General Procedure 1 with the exception that 
2.0 equivalents TiCl4 and 15.0 equivalents KOtBu were used in this procedure. The crude 
residue was purified by column chromatography (silica, 0 to 20% Et2O/hexanes) to yield 
17.5 mg of 128 (27% yield, 2:1 dr, >20:1 E:Z, 65% major isomer) as a yellow oil. Rf = 0.22 
(silica, 10% EtOAc/hexane, UV). [𝒂]𝑫𝟐𝟓	 = +13° (c = 1.0, CHCl3). 
1H NMR (400 MHz, 
CDCl3): Note: mixture of diastereomers: δ 7.41 – 7.19 (m, 10.0H), 6.66 – 6.36 (m, 1H), 
6.26 – 5.89 (m, 1H), 4.49 (d, J = 8.5 Hz, 2H), 4.04 (td, J = 8.2, 5.7 Hz, 0.4H), 3.97 – 3.88 
(m, 1.4H), 3.88 – 3.70 (m, 0.7H), 3.59 (td, J = 8.2, 3.3 Hz, 0.7H), 3.55 – 3.41 (m, 2H), 3.02 
– 2.89 (m, 0.3H), 2.56 (p, J = 8.5 Hz, 0.6H), 2.28 – 2.12 (m, 1H), 1.98 – 1.66 (m, 3.6H), 
1.63 – 1.50 (m, 1.4H). 13C NMR (101 MHz, CDCl3): Note: mixture of diastereomers: δ 
138.75, 138.73, 137.45, 137.28, 131.17, 130.85, 130.60, 129.61, 128.68, 128.52, 128.44, 
128.43, 128.37, 127.73, 127.71, 127.56, 127.40, 127.30, 126.24, 126.21, 83.78, 82.21, 
72.90, 72.84, 72.79, 70.39, 70.30, 67.27, 66.70, 49.38, 45.96, 33.88, 32.84, 30.71, 28.19, 
26.91, 26.77. FTIR (NaCl, thin film, cm-1): 3060, 3027, 2933, 2857, 1495, 1453, 1363, 
1203, 1100, 1073, 1028, 967, 747, 696.  
 
(2R,3R)-2-(4-(benzyloxy)butyl)-3-((E)-styryl)tetrahydrofuran (129)  










(106, 55.6 mg, 1.1 equiv, 0.22 mmol, 98% ee) and 5-(benzyloxy)pentanal (38.5 mg, 1.0 
equiv, 0.2 mmol) according to General Procedure 1 with the exception that 2.0 equivalents 
TiCl4 and 15.0 equivalents KOtBu were used in this procedure. The crude residue was 
purified by column chromatography (silica, 0 to 15% Et2O/hexanes) to yield 13.7 mg of 
129 (20% yield, 10:1 dr, >20:1 E:Z, 90% major isomer) as a colorless oil. Rf = 0.18 (silica, 
10% EtOAc/hexane, UV).  [𝒂]𝑫𝟐𝟓	 = +48° (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): 
δ 7.39 – 7.12 (m, 10H), 6.44 (d, J = 15.7 Hz, 1H), 6.10 (dd, J = 15.8, 8.8 Hz, 1H), 4.48 (s, 
2H), 3.90 (d, J = 8.1 Hz, 2H), 3.56 (td, J = 7.8, 3.3 Hz, 1H), 3.46 (td, J = 6.5, 2.8 Hz, 2H), 
2.53 (p, J = 8.6 Hz, 1H), 2.19 (dddd, J = 12.0, 8.1, 6.5, 5.3 Hz, 1H), 1.93 – 1.82 (m, 1H), 
1.69 – 1.45 (m, 6H). 13C NMR (101 MHz, CDCl3): δ 138.8, 137.3, 131.1, 130.7, 128.7, 
128.4, 127.7, 127.6, 127.4, 126.2, 84.0, 73.0, 70.5, 67.3, 49.4, 33.9, 33.9, 30.0, 23.3. FTIR 
(NaCl, thin film, cm-1): 3027, 2935, 2860, 1495, 1454, 1363, 1102, 1028, 1017, 966, 747, 
696.  
 
General Procedure 2: Condensation/Allylation for cis-2,3-tetrahydrofurans 
 
On a bench-top open to an atmosphere of air, the allylic silane (0.22 mmol, 1.1 equiv), 
aldehyde (0.2 mmol, 1.0 equiv) and CH2Cl2 (2 mL, 0.1M) were added to a 25 mL round 
bottom flask equipped with a stir bar. The TMSOTf (0.06 mmol, 0.03 equiv) was added to 
the flask and the reaction was allowed to stir at room temperature for 5 minutes before 










solution was concentrated under reduced pressure. The resulting powder was then loaded 
onto a silica column and purified via column chromatography to yield the desired product. 
(2S,3R)-2-ethyl-3-((E)-styryl)tetrahydrofuran (110) 
Prepared from (S,E)-5-phenyl-5-(trimethylsilyl)pent-3-en-1-ol (107, 51.6 
mg, 1.1 equiv, 0.22 mmol, 98% ee) and propionaldehyde (11.6 mg, 1.0 
equiv, 0.2 mmol) according to General Procedure 2. The crude residue was purified by 
column chromatography (silica, 0 to 5% Et2O/hexanes) to yield 39.6 mg of 110 (98% yield, 
>20:1 dr, >20:1 E:Z, 93% major isomer) as a colorless oil. Rf = 0.36 (silica, 10% 
EtOAc/hexane, UV).  [𝒂]𝑫𝟐𝟓	 = +28° (c = 1.0, CHCl3). 
1H NMR (500 MHz, CDCl3): δ 7.39 
– 7.34 (m, 2H), 7.34 – 7.27 (m, 2H), 7.25 – 7.19 (m, 1H), 6.41 (d, J = 15.8 Hz, 1H), 6.18 
(dd, J = 15.8, 9.7 Hz, 1H), 4.05 (td, J = 8.3, 5.9 Hz, 1H), 3.86 – 3.73 (m, 2H), 2.95 (ddt, J = 
12.5, 10.0, 5.2 Hz, 1H), 2.22 (dddd, J = 12.5, 8.4, 7.5, 5.9 Hz, 1H), 1.89 (dddd, J = 12.6, 
8.1, 6.4, 4.7 Hz, 1H), 1.62 – 1.42 (m, 2H), 0.96 (t, J = 7.4 Hz, 3H). 13C NMR (126 MHz, 
CDCl3): δ 137.5, 130.7, 129.7, 128.7, 127.3, 126.2, 126.2, 84.0, 66.6, 45.7, 32.9, 24.5, 
10.9. FTIR (NaCl, thin film, cm-1): 3026, 2964, 2934, 2874, 1494, 1463, 1450, 1359, 
1101, 1063, 1033, 970, 750, 694.  
 
(2S,3R)-2-isopropyl-3-((E)-styryl)tetrahydrofuran (111) 
Prepared from (S,E)-5-phenyl-5-(trimethylsilyl)pent-3-en-1-ol (107, 51.6 
mg, 1.1 equiv, 0.22 mmol, 98% ee) and isobutylaldehyde (14.4 mg, 1.0 
equiv, 0.2 mmol) according to General Procedure 2. The crude residue was purified by 










17:1 dr, >20:1 E:Z, 92% major isomer) as a colorless oil. Rf = 0.45 (silica, 10% 
EtOAc/hexane, UV).  [𝒂]𝑫𝟐𝟓	 = +58° (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ 7.40 
– 7.35 (m, 2H), 7.35 – 7.29 (m, 2H), 7.25 – 7.19 (m, 1H), 6.40 (s, 1H), 6.24 (dd, J = 15.8, 
10.0 Hz, 1H), 4.06 (q, J = 8.0 Hz, 1H), 3.86 (ddd, J = 9.4, 8.4, 4.6 Hz, 1H), 3.33 (dd, J = 
9.8, 4.5 Hz, 1H), 2.97 – 2.89 (m, 1H), 2.27 (ddt, J = 12.6, 9.4, 7.5 Hz, 1H), 1.88 (dddd, J = 
12.5, 7.9, 4.6, 2.0 Hz, 1H), 1.81 – 1.70 (m, 1H), 1.05 (d, J = 6.5 Hz, 3H), 0.87 (d, J = 6.6 
Hz, 3H). 13C NMR (101 MHz, CDCl3): δ 137.5, 130.4, 129.6, 128.7, 127.2, 126.2, 88.8, 
66.4, 45.0, 33.5, 29.5, 20.7, 18.9. FTIR (NaCl, thin film, cm-1): 2958, 2872, 1494, 1450, 
1388, 1066, 970, 754, 694.  
 
(2S,3R)-2-cyclohexyl-3-((E)-styryl)tetrahydrofuran (115)  
Prepared from (S,E)-5-phenyl-5-(trimethylsilyl)pent-3-en-1-ol (107, 51.6 
mg, 1.1 equiv, 0.22 mmol, 98% ee) and cyclohexanecarbaldehyde (22.4 
mg, 1.0 equiv, 0.2 mmol) according to General Procedure 2. The crude residue was purified 
by column chromatography (silica, 0 to 5% Et2O/hexanes) to yield 50.6 mg of 115 (99% 
yield, >20:1 dr, >20:1 E:Z, 95% major isomer) as a colorless oil which crystallized upon 
standing. Crystals suitable for X-ray diffraction were grown from hexane upon standing in 
the freezer (–20 °C). Rf = 0.43 (silica, 10% EtOAc/hexane, UV). [𝒂]𝑫𝟐𝟓	 = +81° (c = 1.0, 
CHCl3). 1H NMR (400 MHz, CDCl3): δ 7.40 – 7.35 (m, 2H), 7.32 (dd, J = 8.5, 6.7 Hz, 
2H), 7.26 – 7.20 (m, 1H), 6.41 (d, J = 15.8 Hz, 1H), 6.24 (dd, J = 15.9, 9.9 Hz, 1H), 4.04 
(q, J = 8.0 Hz, 1H), 3.84 (ddd, J = 9.5, 8.4, 4.6 Hz, 1H), 3.39 (dd, J = 9.7, 4.5 Hz, 1H), 2.93 






1H), 1.87 (dddd, J = 12.5, 7.9, 4.6, 2.0 Hz, 1H), 1.77 – 1.68 (m, 2H), 1.68 – 1.60 (m, 2H), 
1.48 (dddd, J = 13.2, 8.1, 7.0, 3.5 Hz, 1H), 1.32 – 1.12 (m, 3H), 1.05 (tdd, J = 12.5, 10.9, 
3.5 Hz, 1H), 0.97 – 0.82 (m, 1H). 13C NMR (101 MHz, CDCl3): δ 137.7, 130.4, 129.7, 
128.6, 127.2, 126.2, 87.3, 66.2, 44.6, 38.9, 33.4, 31.0, 28.9, 26.6, 25.9, 25.8. FTIR (NaCl, 
thin film, cm-1): 2924, 2851, 1492, 1449, 1062, 970, 884, 753, 693. 
 
(2S,3R)-2-(4-chlorobutyl)-3-((E)-styryl)tetrahydrofuran (118) 
Prepared from (S,E)-5-phenyl-5-(trimethylsilyl)pent-3-en-1-ol (107, 51.6 
mg, 1.1 equiv, 0.22 mmol, 98% ee) and 5-chloropentanal (24.1 mg, 1.0 
equiv, 0.2 mmol) according to General Procedure 2. The crude residue was purified by 
column chromatography (silica, 0 to 10% Et2O/hexanes) to yield 39.9 mg of 118 (75% 
yield, 8:1 dr, >20:1 E:Z, 87% major isomer) as a colorless oil. Rf = 0.27 (silica, 10% 
EtOAc/hexane, UV).  [𝒂]𝑫𝟐𝟓	 = +29° (c = 0.5, CHCl3). 
1H NMR (400 MHz, CDCl3): δ 7.40 
– 7.35 (m, 2H), 7.35 – 7.29 (m, 2H), 7.25 – 7.20 (m, 1H), 6.42 (d, J = 15.8 Hz, 1H), 6.16 
(dd, J = 15.8, 9.6 Hz, 1H), 4.05 (td, J = 8.2, 5.8 Hz, 1H), 3.87 – 3.77 (m, 2H), 3.51 (t, J = 
6.7 Hz, 2H), 2.95 (ddt, J = 10.1, 7.4, 5.3 Hz, 1H), 2.22 (dddd, J = 12.4, 8.4, 7.5, 5.8 Hz, 
1H), 1.89 (dddd, J = 12.7, 8.1, 6.5, 4.8 Hz, 1H), 1.84 – 1.72 (m, 2H), 1.66 – 1.41 (m, 4H). 
13C NMR (101 MHz, CDCl3): δ 137.4, 130.9, 129.5, 128.7, 127.3, 126.2, 82.2, 66.7, 45.9, 
45.1, 32.8, 32.7, 30.8, 24.1. FTIR (NaCl, thin film, cm-1): 2934, 2867, 1493, 1449, 1073, 









(2S,3R)-2-(but-3-en-1-yl)-3-((E)-styryl)tetrahydrofuran (114)  
Prepared from (S,E)-5-phenyl-5-(trimethylsilyl)pent-3-en-1-ol (107, 51.6 
mg, 1.1 equiv, 0.22 mmol, 98% ee) and pent-4-enal (16.8 mg, 1.0 equiv, 
0.2 mmol) according to General Procedure 2. The crude residue was purified by column 
chromatography (silica, 0 to 5% Et2O/hexanes) to yield 28.4 mg of 114 (62% yield, >20:1 
dr, >20:1 E:Z, 94% major isomer) as a colorless oil. Rf = 0.43 (silica, 10% EtOAc/hexane, 
UV).  [𝒂]𝑫𝟐𝟓	 = +49° (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ 7.39 – 7.34 (m, 2H), 
7.34 – 7.29 (m, 2H), 7.25 – 7.20 (m, 1H), 6.42 (d, J = 15.8 Hz, 1H), 6.17 (dd, J = 15.8, 9.6 
Hz, 1H), 5.82 (ddt, J = 16.9, 10.2, 6.7 Hz, 1H), 5.06 – 4.92 (m, 2H), 4.05 (td, J = 8.3, 5.7 
Hz, 1H), 3.90 – 3.78 (m, 2H), 3.01 – 2.91 (m, 1H), 2.28 – 2.17 (m, 2H), 2.17 – 2.05 (m, 
1H), 1.89 (dddd, J = 12.8, 8.1, 6.6, 5.0 Hz, 1H), 1.67 – 1.48 (m, 2H). 13C NMR (101 MHz, 
CDCl3): δ 138.6, 137.4, 130.7, 129.6, 128.7, 127.3, 126.2, 126.2, 114.8, 81.7, 67.0, 45.9, 
32.9, 30.9, 30.8. FTIR (NaCl, thin film, cm-1): 3026, 2974, 2937, 2871, 1640, 1449, 1066, 
1051, 969, 911, 750, 694. 
 
(2R,3R)-2-((benzyloxy)methyl)-3-((E)-styryl)tetrahydrofuran (124)  
Prepared from (S,E)-5-phenyl-5-(trimethylsilyl)pent-3-en-1-ol (107, 51.6 
mg, 1.1 equiv, 0.22 mmol, 98% ee) and 2-(benzyloxy)acetaldehyde (30.0 
mg, 1.0 equiv, 0.2 mmol) according to General Procedure 2. The crude residue was purified 
by column chromatography (silica, 0 to 15% Et2O/hexanes) to yield 38.2 mg of 124 (65% 
yield, 19:1 dr, 18:1 E:Z, 90% major isomer) as a colorless oil. Rf = 0.17 (silica, 10% 
EtOAc/hexane, UV).  [𝒂]𝑫𝟐𝟓	 = +29° (c = 1.0, CHCl3). 








– 7.21 (m, 10H), 6.45 (d, J = 15.8 Hz, 1H), 6.20 (dd, J = 15.8, 9.4 Hz, 1H), 4.55 (q, J = 
12.1 Hz, 2H), 4.18 – 4.10 (m, 2H), 3.87 (q, J = 7.8 Hz, 1H), 3.59 – 3.50 (m, 2H), 3.09 (dq, 
J = 9.4, 6.9 Hz, 1H), 2.20 (dtd, J = 12.5, 7.6, 4.9 Hz, 1H), 1.98 (dtd, J = 12.3, 7.7, 6.4 Hz, 
1H) 13C NMR (101 MHz, CDCl3): δ 138.3, 137.3, 131.2, 128.8, 128.6, 128.4, 127.8, 
127.6, 127.4, 126.2, 80.9, 73.6, 71.1, 67.8, 45.3, 32.9. FTIR (NaCl, thin film, cm-1): 3027, 
2919, 2861, 1495, 1451, 1361, 1076, 1027, 970, 748, 695. 
 
(2S,3R)-2-(2-(benzyloxy)ethyl)-3-((E)-styryl)tetrahydrofuran (119)  
Prepared from (S,E)-5-phenyl-5-(trimethylsilyl)pent-3-en-1-ol (107, 51.6 
mg, 1.1 equiv, 0.22 mmol, 98% ee) and 3-(benzyloxy)propanal (32.8 mg, 
1.0 equiv, 0.2 mmol) according to General Procedure 2. The crude residue was purified by 
column chromatography (silica, 0 to 15% Et2O/hexanes) to yield 50.3 mg of 119 (82% 
yield, 15:1 dr, 15:1 E:Z, 88% major isomer) as a colorless oil. Rf = 0.20 (silica, 10% 
EtOAc/hexane, UV).  [𝒂]𝑫𝟐𝟓	 = +49° (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ 7.39 
– 7.20 (m, 10H), 6.40 (d, J = 15.8 Hz, 1H), 6.17 (dd, J = 15.8, 9.5 Hz, 1H), 4.57 – 4.48 (m, 
2H), 4.10 – 4.02 (m, 2H), 3.83 (td, J = 8.3, 6.7 Hz, 1H), 3.62 (td, J = 6.7, 3.6 Hz, 2H), 2.97 
(ddt, J = 9.6, 7.3, 5.5 Hz, 1H), 2.30 – 2.14 (m, 1H), 1.90 (dddd, J = 12.1, 8.2, 6.7, 5.1 Hz, 
1H), 1.82 (q, J = 6.8 Hz, 2H). 13C NMR (101 MHz, CDCl3): δ 138.6, 137.3, 131.0, 129.4, 
128.6, 128.4, 127.8, 127.6, 127.3, 126.2, 79.2, 73.2, 68.0, 66.8, 45.9, 32.7, 31.9. FTIR 










Prepared from (S,E)-5-phenyl-5-(trimethylsilyl)pent-3-en-1-ol (107, 51.6 
mg, 1.1 equiv, 0.22 mmol, 98% ee) and 4-(benzyloxy)butanal (35.6 mg, 
1.0 equiv, 0.2 mmol) according to General Procedure 2. The crude residue was purified by 
column chromatography (silica, 0 to 15% Et2O/hexanes) to yield 47.4 mg of 125 (74% 
yield, >20:1 dr, 19:1 E:Z, 92% major isomer) as a colorless oil. Rf = 0.17 (silica, 10% 
EtOAc/hexane, UV).  [𝒂]𝑫𝟐𝟓	 = +33° (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ 7.43 
– 7.20 (m, 10H), 6.43 (d, J = 15.8 Hz, 1H), 6.19 (dd, J = 15.8, 9.6 Hz, 1H), 4.49 (s, 2H), 
4.06 (td, J = 8.3, 5.7 Hz, 1H), 3.92 – 3.78 (m, 2H), 3.49 (qt, J = 9.3, 6.4 Hz, 2H), 3.02 – 
2.92 (m, 1H), 2.22 (dtd, J = 13.4, 7.9, 5.6 Hz, 1H), 1.96 – 1.85 (m, 1H), 1.85 – 1.76 (m, 
1H), 1.76 – 1.65 (m, 1H), 1.58 (q, J = 7.1 Hz, 2H). 13C NMR (101 MHz, CDCl3): δ 138.7, 
137.4, 130.8, 129.6, 128.6, 128.4, 127.7, 127.5, 127.3, 126.2, 82.2, 72.8, 70.3, 66.7, 45.9, 
32.8, 28.2, 26.9. FTIR (NaCl, thin film, cm-1): 3027, 2934, 2855, 1495, 1452, 1362, 1100, 
1073, 1028, 970, 749, 737, 696. 
 
(2S,3R)-2-(4-(benzyloxy)butyl)-3-((E)-styryl)tetrahydrofuran (126)  
Prepared from (S,E)-5-phenyl-5-(trimethylsilyl)pent-3-en-1-ol (107, 
51.6 mg, 1.1 equiv, 0.22 mmol, 98% ee) and 5-(benzyloxy)pentanal 
(38.5 mg, 1.0 equiv, 0.2 mmol) according to General Procedure 2. The crude residue was 
purified by column chromatography (silica, 0 to 15% Et2O/hexanes) to yield 40.1 mg of 
126 (60% yield, 20:1 dr, >20:1 E:Z, 92% major isomer) as a colorless oil. Rf = 0.23 (silica, 
10% EtOAc/hexane, UV).  [𝒂]𝑫𝟐𝟓	 = +38° (c = 1.0, CHCl3). 










δ 7.38 – 7.21 (m, 10H), 6.41 (d, J = 15.8 Hz, 1H), 6.17 (dd, J = 15.8, 9.6 Hz, 1H), 4.47 (s, 
2H), 4.05 (td, J = 8.2, 5.8 Hz, 1H), 3.89 – 3.78 (m, 2H), 3.46 (t, J = 6.5 Hz, 2H), 2.99 – 
2.88 (m, 1H), 2.22 (dddd, J = 12.5, 8.4, 7.5, 5.8 Hz, 1H), 1.88 (dddd, J = 12.7, 8.1, 6.4, 4.7 
Hz, 1H), 1.69 – 1.39 (m, 6H). 13C NMR (101 MHz, CDCl3): δ 138.8, 137.5, 130.7, 129.7, 
128.7, 128.4, 127.7, 127.5, 127.3, 126.2, 82.4, 72.9, 70.4, 66.6, 45.9, 32.9, 31.3, 29.9, 23.3. 
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